This Article is no longer available, this page is showing similar articles.

Food, Drugs, Healthcare, Life Sciences

Subscribe

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.

Bring Out Your Meds! Bring Out Your Meds!

With a nod to the immortal phrase, "Bring out your dead! Bring out your dead!" uttered by body collector Eric Idle from the 1975 comedy romp, Monty Python and the Holy Grail...

United States Healthcare

HP

Hyman, Phelps, & McNamara

Where Have All The Good Guidance Gone?

While this author needs no excuse to listen to Van Halen, one surprising source of inspiration came while reviewing the body of guidance documents issued by CDRH in the last year.

United States Healthcare

HP

Hyman, Phelps, & McNamara

Strengthening Postapproval Monitoring: FDA's Draft Guidance On Cell & Gene Therapy Products

FDA recently released a draft guidance, titled "Postapproval Methods to Capture Safety and Efficacy Data for Cell and Gene Therapy Products,"...

United States Healthcare

HP

Hyman, Phelps, & McNamara

Real Food, Healthy Kids – And It's Not An Act

Actually, it is. No sooner had FDA flagged its intent to maybe eventually hammer out a federal definition of ultra-processed foods than California leapfrogged ahead with the Real Food, Healthy Kids Act (a/k/a AB 1264).

United States Healthcare

HP

Hyman, Phelps, & McNamara

RRA, RIE And MRA: FDA's Evolving Inspection Toolkit Still Has Boundaries

United States Healthcare

HP

Hyman, Phelps, & McNamara

BIOSECURE Act Advances In The US Senate

United States Healthcare

GT

Greenberg Traurig, LLP

FDA Proposes To Remove Comparative Efficacy Studies To Accelerate Biosimilar Development

United States Healthcare

JD

Jones Day

The Profit Crunch: How US Policy Could Reshape Global Pharma Research And Development (R&D)

Worldwide Healthcare

AM

Alvarez & Marsal

California's 2026 APRN Practice Reforms: What AB 583 And AB 876 Mean For NPs, CRNAs, And Healthcare Facilities

United States Healthcare

DW

Davis Wright Tremaine

Health Headlines: October 2025

United States Healthcare

GP

Goodwin Procter LLP

Current Opportunities And Challenges In RWE And Its Future With AI

United States Healthcare

HP

Hyman, Phelps, & McNamara

Senate Passes Revised Version Of The BIOSECURE Act

United States Healthcare

HP

Hyman, Phelps, & McNamara

RWE And AI: Hand In Hand In The Future Of Regulatory Decision Making

United States Healthcare

HP

Hyman, Phelps, & McNamara

Inaugural Class Of Commissioner's National Priority Voucher Recipients Announced

United States Healthcare

HP

Hyman, Phelps, & McNamara

See more

Webinars

See More

Recorded on 24 Jun 2025 | 3:00 PM

(2nd Session) 2025 Global In-House Counsel Survey Report: Unique Insights into the Global In-House Counsel Profession

IC

In-House Counsel Worldwide

Recorded on 24 Jun 2025 | 9:00 AM

(1st Session) 2025 Global In-House Counsel Survey Report: Unique Insights into the Global In-House Counsel Profession

IC

In-House Counsel Worldwide

Recorded on 30 Apr 2025 | 2:00 PM

Mondaq | 2025 Law Firm Data Landscape Report

mm

Mondaq

Recorded on 21 Jan 2025 | 3:00 PM

2025 Canadian In-House Counsel Report: Unparalleled Insights into Canada's In-House Profession from CCCA | Mondaq

TC

CBA In-House Lawyers

Highlighted Content

Plausibility At The EPO – An Update On G2/21

United States Healthcare

D

Dehns

Infringement Of Repurposed Drug Patents And Skinny Labelling – Where Does The Balance Lie In The United States Today?

United States Healthcare

D

Dehns

Infringement Of Repurposed Drug Patents And Skinny Labelling – Where Does The Balance Lie In Europe Today?

United States Healthcare

D

Dehns

How Good Does A Copy Need To Be?

United States Healthcare

D

Dehns

Supplementary Protection Certificates – European Patent Term Extensions

United States Healthcare

D

Dehns

How Much Experimental Data Is Needed For Patent Applications In Europe?

United States Healthcare

D

Dehns

The Silent Treatment: The EPO's Approach To Non-therapeutic Methods Encompassing Therapeutic Effects

United States Healthcare

D

Dehns

Implications Of The Genetic Technology (Precision Breeding) Bill On The Life Science IP Sector

United States Healthcare

D

Dehns

Protection For Plant Varieties In Europe And The UK Post-Brexit

United States Healthcare

D

Dehns

Best Practice For Invention Harvesting

United States Healthcare

D

Dehns

Food and Drugs Law

Bring Out Your Meds! Bring Out Your Meds!

With a nod to the immortal phrase, "Bring out your dead! Bring out your dead!" uttered by body collector Eric Idle from the 1975 comedy romp, Monty Python and the Holy Grail...

United States Healthcare

HP

Hyman, Phelps, & McNamara

Where Have All The Good Guidance Gone?

While this author needs no excuse to listen to Van Halen, one surprising source of inspiration came while reviewing the body of guidance documents issued by CDRH in the last year.

United States Healthcare

HP

Hyman, Phelps, & McNamara

Strengthening Postapproval Monitoring: FDA's Draft Guidance On Cell & Gene Therapy Products

FDA recently released a draft guidance, titled "Postapproval Methods to Capture Safety and Efficacy Data for Cell and Gene Therapy Products,"...

United States Healthcare

HP

Hyman, Phelps, & McNamara

Real Food, Healthy Kids – And It's Not An Act

United States Healthcare

HP

Hyman, Phelps, & McNamara

RRA, RIE And MRA: FDA's Evolving Inspection Toolkit Still Has Boundaries

United States Healthcare

HP

Hyman, Phelps, & McNamara

FDA Proposes To Remove Comparative Efficacy Studies To Accelerate Biosimilar Development

United States Healthcare

JD

Jones Day

The Profit Crunch: How US Policy Could Reshape Global Pharma Research And Development (R&D)

Worldwide Healthcare

AM

Alvarez & Marsal

Health Headlines: October 2025

United States Healthcare

GP

Goodwin Procter LLP

Current Opportunities And Challenges In RWE And Its Future With AI

United States Healthcare

HP

Hyman, Phelps, & McNamara

See more

Life Sciences, Biotechnology & Nanotechnology

Bring Out Your Meds! Bring Out Your Meds!

With a nod to the immortal phrase, "Bring out your dead! Bring out your dead!" uttered by body collector Eric Idle from the 1975 comedy romp, Monty Python and the Holy Grail...

United States Healthcare

HP

Hyman, Phelps, & McNamara

Where Have All The Good Guidance Gone?

While this author needs no excuse to listen to Van Halen, one surprising source of inspiration came while reviewing the body of guidance documents issued by CDRH in the last year.

United States Healthcare

HP

Hyman, Phelps, & McNamara

BIOSECURE Act Advances In The US Senate

On Oct. 9, the U.S. Senate passed the BIOSECURE Act as an amendment to the National Defense Authorization Act (NDAA).

United States Healthcare

GT

Greenberg Traurig, LLP

FDA Proposes To Remove Comparative Efficacy Studies To Accelerate Biosimilar Development

United States Healthcare

JD

Jones Day

The Profit Crunch: How US Policy Could Reshape Global Pharma Research And Development (R&D)

Worldwide Healthcare

AM

Alvarez & Marsal

Senate Passes Revised Version Of The BIOSECURE Act

United States Healthcare

HP

Hyman, Phelps, & McNamara

HHS Divided: Can Consumers Be Trusted With Low-Risk Products?

United States Healthcare

HP

Hyman, Phelps, & McNamara

New FDA Guidance Could Speed Biosimilar Approvals And Cut Costs

United States Healthcare

PL

Polsinelli LLP

Key Healthcare And Life Sciences Regulatory Updates And Enforcement Trends In 2025 & Beyond

United States Healthcare

BI

Buchanan Ingersoll & Rooney PC

See more

Healthcare

Where Have All The Good Guidance Gone?

While this author needs no excuse to listen to Van Halen, one surprising source of inspiration came while reviewing the body of guidance documents issued by CDRH in the last year.

United States Healthcare

HP

Hyman, Phelps, & McNamara

The Profit Crunch: How US Policy Could Reshape Global Pharma Research And Development (R&D)

US pharmaceutical companies have long been a dominant force in global foreign direct investment (FDI), contributing around 25% of outbound FDI in the sector and over half of global pharmaceutical research and development...

Worldwide Healthcare

AM

Alvarez & Marsal

Shutdown Patience Wearing Thin? (Beltway Buzz, October 31, 2025)

The Beltway Buzz™ is a weekly update summarizing labor and employment news from inside the Beltway and clarifying how what's happening in Washington, D.C., could impact your business.

United States Employment

OD

Ogletree, Deakins, Nash, Smoak & Stewart

California's 2026 APRN Practice Reforms: What AB 583 And AB 876 Mean For NPs, CRNAs, And Healthcare Facilities

United States Healthcare

DW

Davis Wright Tremaine

Health Headlines: October 2025

United States Healthcare

GP

Goodwin Procter LLP

Current Opportunities And Challenges In RWE And Its Future With AI

United States Healthcare

HP

Hyman, Phelps, & McNamara

Ready Or Not: HRSA's 340B Rebate Pilot Model Takes Off Despite Questions On Readiness And Authority

United States Healthcare

PL

Polsinelli LLP

DOJ's Subpoena Strategy On Transgender Care Faces Judicial And State Pushback

United States Healthcare

M

Mintz

A Look Ahead: Major Industry Trends Our Healthcare Team Is Tracking

United States Healthcare

SM

Sheppard Mullin Richter & Hampton

See more

Latest Videos

See more

Navigating Health Plan M&A: Strategies For Success In The Medicare Advantage Market (Podcast)

RG

Ropes & Gray LLP

WHLC Summit - Day Two Recording (Video)

SM

Sheppard Mullin Richter & Hampton

Redefining Healthcare Leadership: Dr. Heather Farley On The Inaugural Role Of Chief Well-being Officer At MUSC (Video)

AM

Alvarez & Marsal

Navigating Women's Health With Rachel Welch (Video)

OK

Offit Kurman

Inside MedTech Translation Challenges: Ensuring Multilingual Regulatory Compliance

Moringside

Upcoming Events

37th Annual Health Law Forum

United States Healthcare

BB

Bass, Berry & Sims

Complete Response Letters In Transition: Navigating FDA’s Transparency Policy And Manufacturing-Related Actions, And How To Respond

United States Healthcare

AP

Arnold & Porter

HCCA Nashville Regional Healthcare Compliance Conference

United States Healthcare

BB

Bass, Berry & Sims

Global MedTech Showcase By One Six 8 Ventures

United States Healthcare

M

Mintz

TSCPA Health Care Conference

United States Healthcare

BB

Bass, Berry & Sims

Business Breakfast

The Future Of Aging In New York

United States Healthcare

SM

Sheppard Mullin Richter & Hampton

Healthcare Enforcement Compliance Conference

United States Healthcare

BB

Bass, Berry & Sims

Dr. Mandy Cohen To Speak At Duke University School Of Medicine Grand Rounds

United States Healthcare

MP

Manatt, Phelps & Phillips LLP

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More